Keros Therapeutics Presents Clinical Data From Its Elritercept Program At The 66Th American Society Of Hematology Annual Meeting And Exposition
Keros Therapeutics Presents Clinical Data From Its Elritercept Program At The 66Th American Society Of Hematology Annual Meeting And Exposition . (MENAFN - GlobeNewsWire - Nasdaq)    Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108973903/Keros-Therapeutics-Presents-Clinical-Data-From-Its-Elritercept-Program-At-The-66Th-American-Society-Of-Hematology-Annual-Meeting-And-Exposition
2024-12-09
rss
(MENAFN - GlobeNewsWire - Nasdaq)    Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a ...
Keros Therapeutics Presents Clinical Data From Its Elritercept Program At The 66Th American Society Of Hematology Annual Meeting And Exposition